127 related articles for article (PubMed ID: 28672959)
1. Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.
Wang W; Zheng Y; Jia J; Li C; Duan Q; Li R; Wang X; Shao Y; Chen C; Yan H
Exp Ther Med; 2017 Jul; 14(1):499-506. PubMed ID: 28672959
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial peptide LL-37 promotes the proliferation and invasion of skin squamous cell carcinoma by upregulating DNA-binding protein A.
Wang W; Jia J; Li C; Duan Q; Yang J; Wang X; Li R; Chen C; Yan H; Zheng Y
Oncol Lett; 2016 Sep; 12(3):1745-1752. PubMed ID: 27588122
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells.
Jia J; Zheng Y; Wang W; Shao Y; Li Z; Wang Q; Wang Y; Yan H
Mol Med Rep; 2017 Jan; 15(1):240-248. PubMed ID: 27922666
[TBL] [Abstract][Full Text] [Related]
4. Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells.
Wang H; Sun R; Chi Z; Li S; Hao L
Mol Cell Biochem; 2017 Sep; 433(1-2):1-12. PubMed ID: 28382490
[TBL] [Abstract][Full Text] [Related]
5. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells.
Shen H; Ma JL; Zhang Y; Deng GL; Qu YL; Wu XL; He JX; Zhang S; Zeng S
World J Gastroenterol; 2016 Apr; 22(15):3969-77. PubMed ID: 27099440
[TBL] [Abstract][Full Text] [Related]
6. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
[TBL] [Abstract][Full Text] [Related]
7. YB-1 promotes laryngeal squamous cell carcinoma progression by inducing miR-155 expression via c-Myb.
Zhao X; Zhang W; Ji W
Future Oncol; 2018 Jul; 14(16):1579-1589. PubMed ID: 29517281
[TBL] [Abstract][Full Text] [Related]
8. [Extracellular Y-box binding protein-1 promotes proliferation and metastasis of HepG2 cells through Notch3 receptor].
Shi J; Li P; Zou L; Chen P; Zhang LP
Zhonghua Gan Zang Bing Za Zhi; 2016 Mar; 24(3):202-6. PubMed ID: 27095764
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-21 regulates the ERK/NF-κB signaling pathway to affect the proliferation, migration, and apoptosis of human melanoma A375 cells by targeting SPRY1, PDCD4, and PTEN.
Mao XH; Chen M; Wang Y; Cui PG; Liu SB; Xu ZY
Mol Carcinog; 2017 Mar; 56(3):886-894. PubMed ID: 27533779
[TBL] [Abstract][Full Text] [Related]
10. Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells.
Basaki Y; Hosoi F; Oda Y; Fotovati A; Maruyama Y; Oie S; Ono M; Izumi H; Kohno K; Sakai K; Shimoyama T; Nishio K; Kuwano M
Oncogene; 2007 Apr; 26(19):2736-46. PubMed ID: 17072343
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
[TBL] [Abstract][Full Text] [Related]
12. CD44v6 may influence ovarian cancer cell invasion and migration by regulating the NF-κB pathway.
Wang Y; Yang X; Xian S; Zhang L; Cheng Y
Oncol Lett; 2019 Jul; 18(1):298-306. PubMed ID: 31289500
[TBL] [Abstract][Full Text] [Related]
13. Identification of 2,4-dihydroxy-5-pyrimidinyl imidothiocarbomate as a novel inhibitor to Y box binding protein-1 (YB-1) and its therapeutic actions against breast cancer.
Gunasekaran VP; Nishi K; Sivakumar D; Sivaraman T; Mathan G
Eur J Pharm Sci; 2018 Apr; 116():2-14. PubMed ID: 28916481
[TBL] [Abstract][Full Text] [Related]
14. Tumour Progression Stage-Dependent Secretion of YB-1 Stimulates Melanoma Cell Migration and Invasion.
Kosnopfel C; Sinnberg T; Sauer B; Niessner H; Muenchow A; Fehrenbacher B; Schaller M; Mertens PR; Garbe C; Thakur BK; Schittek B
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32824741
[TBL] [Abstract][Full Text] [Related]
15. Chloride channel-3 is required for efficient tumour cell migration and invasion in human cervical squamous cell carcinoma.
Guan Y; Luan Y; Xie Y; Zhou H; Li W; Zhang X; Shen X; Chen Y; Xu L; Lin Z; Wang G
Gynecol Oncol; 2019 Jun; 153(3):661-669. PubMed ID: 30905432
[TBL] [Abstract][Full Text] [Related]
16. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop.
Sinnberg T; Sauer B; Holm P; Spangler B; Kuphal S; Bosserhoff A; Schittek B
Exp Dermatol; 2012 Apr; 21(4):265-70. PubMed ID: 22417301
[TBL] [Abstract][Full Text] [Related]
17. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
[TBL] [Abstract][Full Text] [Related]
18. Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway.
Chao HM; Huang HX; Chang PH; Tseng KC; Miyajima A; Chern E
Oncotarget; 2017 Jan; 8(2):2604-2616. PubMed ID: 27911878
[TBL] [Abstract][Full Text] [Related]
19. The activation of the NF-κB-JNK pathway is independent of the PI3K-Rac1-JNK pathway involved in the bFGF-regulated human fibroblast cell migration.
Xuan Y; Chi L; Tian H; Cai W; Sun C; Wang T; Zhou X; Shao M; Zhu Y; Niu C; Sun Y; Cong W; Zhu Z; Li Z; Wang Y; Jin L
J Dermatol Sci; 2016 Apr; 82(1):28-37. PubMed ID: 26829882
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer.
Kashihara M; Azuma K; Kawahara A; Basaki Y; Hattori S; Yanagawa T; Terazaki Y; Takamori S; Shirouzu K; Aizawa H; Nakano K; Kage M; Kuwano M; Ono M
J Thorac Oncol; 2009 Sep; 4(9):1066-74. PubMed ID: 19648825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
